Healthtech Security

Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines

PRnewsiwire | June 05, 2023 | Read time : 04:12 min

Carrum Health Raises $45 Million Series B to Expand Cancer

Carrum Health today announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity. Revelation Partners joined the round along with return investors Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. Carrum Health will use the funding to expand its growing oncology benefit offerings and scale its surgical care service lines to give employees access to the top 10% of doctors and providers across the country while helping employers control healthcare spending.

Teresa Lee, managing director of OMERS Growth Equity, will join Carrum Health's board of directors.

"We are very excited to partner with Carrum Health, a pioneering and differentiated player in the healthcare space, that offers an innovative, scalable approach in the shift to value-based care. With its Centers of Excellence (COE) network, digital platform and data-driven surgical episode bundling capabilities, Carrum Health has created a solution that allows for real-time and measurable value to employers, as well as a superior patient and clinician experience," said Lee. "The company is well-positioned to transform how healthcare is delivered and paid for, and we look forward to supporting the management team in realizing that vision."

Carrum Health's unique value-based program addresses acute care scenarios, such as orthopedic surgery and cancer treatment, which accounts for nearly half of total employer spend. Carrum Health's COE solution not only reduces unnecessary procedures by as much as 30%, leading to better patient outcomes, it can result in savings of up to 45% per care episode, according to a published study by the RAND Corporation.

"Every business in America is looking to manage costs, but they can't afford to sacrifice the benefits they offer employees. Carrum Health firmly believes that the path to reducing healthcare costs starts with delivering higher quality care," said Carrum Health CEO Sach Jain. "Our COE solution is proven to deliver significant savings on healthcare spend and generate measurable cost savings within the first year of deployment. In a time when employers are looking to consolidate benefits, we've seen 100% year-over-year growth in new customers and zero churn of existing customers."

Carrum Health has seen formidable momentum with its pioneering oncology COE offering and currently partners with top cancer care providers across the country, including AccessHope LLC, City of Hope, GRAIL LLC, Memorial Sloan Kettering Cancer Center and University of Chicago Medicine. In 2022 alone, the company added six new partners, including CVS, Included Health, Accolade, Rightway, SWORD Health and Virgin Pulse.

About Carrum Health

Carrum Health is a value-based healthcare platform delivering higher quality care while helping self-funded employers immediately reduce their spend for the most prevalent and costly conditions including cancer, musculoskeletal, cardiovascular, and bariatric. Utilizing a Centers of Excellence (COE) network, with an all-inclusive pricing model and 30-day warranty on care, Carrum members receive surgical and cancer treatment guidance and coordination through the entire care journey with upfront pricing, ensuring the highest quality, most appropriate care. Carrum reduces unnecessary procedures by as much as 30% and aligns cost and care incentives to save employers up to 45% per episode of care, all validated by peer-reviewed publications. Carrum's award-winning technology gives members access to a mobile app and Care Specialist that guides them through the surgery process, and a seamless platform integration to make COE adoption plug-and-play for employers. Backed by OMERS Growth Equity and Tiger Global, Carrum was named to the 2021 CB Insights Digital Health 150 and named one of the best places to work in 2022 by Built In. The company, founded in 2014, is headquartered in Silicon Valley.

Spotlight

Discover how Futurism AI is revolutionizing the healthcare industry with cutting-edge AI and Machine Learning technologies. Delve into how we leverage AI to predict and prevent equipment failures, monitor disease outbreaks, expedite clinical trials, detect fraudulent activity, and pioneer drug development.

Spotlight

Discover how Futurism AI is revolutionizing the healthcare industry with cutting-edge AI and Machine Learning technologies. Delve into how we leverage AI to predict and prevent equipment failures, monitor disease outbreaks, expedite clinical trials, detect fraudulent activity, and pioneer drug development.

Related News

Health Technology, Digital Healthcare

Johnson and Johnson Embraces New Era with Enhanced Visual Identity

Johnson and Johnson | September 15, 2023

Johnson and Johnson's brand identity communicates the company's bold healthcare innovation while staying true to its global patient care. Leveraging advanced medicine and technology, the company proactively tackles complex diseases with more innovative, less invasive, and personalized solutions. The company plans to gradually implement the new logo, colors, and font across all its materials, product packaging, and branding assets. Johnson and Johnson is currently revitalizing its brand and consolidating its MedTech and pharmaceutical segments under the unified name of Johnson and Johnson, demonstrating a steadfast commitment to healthcare innovation and addressing the most challenging health issues. The announcement signifies a pivotal moment in Johnson and Johnson's evolution as the company harnesses its extensive knowledge of innovative medicine and cutting-edge medical technology. This strategic move aims to proactively address, treat, and ultimately find cures for intricate diseases while simultaneously ushering in solutions characterized by heightened intelligence, reduced invasiveness, and greater personalization, marking a significant stride toward reshaping the future of healthcare. The company's two major segments will become more closely associated with the Johnson and Johnson brand. Over time, Janssen, the company's pharmaceutical part, will assume the name Johnson and Johnson Innovative Medicine, while the medical technology segment will retain the Johnson and Johnson MedTech designation. The pharmaceuticals segment leads the way in advancing healthcare, pioneering treatments to reshape the future of well-being. Johnson and Johnson Innovative Medicine combines a compassionate scientific approach to effectively confront the most complex diseases in oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina to develop future medications. Simultaneously, the medical technology segment dedicates itself to addressing the most pressing healthcare challenges through innovations at the nexus of biology and technology. Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs, stated, Our Johnson and Johnson brand identity communicates our bold approach to innovation in healthcare while staying true to the care we have for our patients around the world. [Source: Business Wire] The updated Johnson and Johnson logo, featuring letters drawn in a single stroke for added contrast and a sense of unexpectedness, embraces both long and short versions, with the 'J&J' abbreviation gaining prominence, especially in digital contexts. The color palette leans toward a refreshed and contemporary red, symbolizing the company's agility in responding to health challenges and evolving with the times. The revamped ampersand now signifies global recognition, openness, and the connections that breathe life into the brand's purpose. In terms of art direction, elements such as illustration and photography have undergone careful curation to evoke energy, optimism, and inclusivity, presenting a distinctive approach within the healthcare domain.

Read More

Healthcare Analytics

CareView Communications Executes Agreement with Baltimore VA Medical Center Under Agreement with Decisive Point Consulting Group, LLC

businesswire | August 31, 2023

CareView Communications, Inc., a leading provider of integrated virtual care solutions for the healthcare industry announced the signing of an agreement with Baltimore VA Medical Center under its partnership with Decisive Point Consulting Group to deploy its advanced predictive patient monitoring system. Decisive Point Consulting Group, LLC, a Small Business Administration Certified Service Disabled Veteran Owned Small Business (SDVOSB), contracts directly with VA hospitals to use a variety of CareView products to enhance the services being provided to veterans. CareView's predictive patient monitoring system leverages state-of-the-art technology, including AI and machine learning, to proactively predict inpatient falls and empower healthcare providers with real-time insights. By using intelligent predictive monitoring, medical staff can proactively address patients at risk, prevent potential accidents, and subsequently reduce costs associated with patient falls while elevating the standard of patient care. A distinctive feature of CareView's platform is creating a serene care environment ideal for VA hospitals by having no audible alarms within patient areas. Patient privacy remains paramount, further fortified by the platform's privacy option, which enhances security and offers peace of mind to patients and their families. "At CareView, we are dedicated to redefining patient care through innovation," stated Sandra McRee, Chief Operating Officer at CareView. "Our collaboration with the Baltimore VA Medical Center signifies a significant leap towards realizing this vision and ensuring the well-being of our nation's veterans." The Baltimore VA Medical Center has eagerly embraced this collaboration, showcasing their strong commitment to implementing innovative solutions that elevate patient safety and the quality of care. This partnership with CareView perfectly aligns with their mission and steadfast dedication to providing the highest standard of care for veterans. Furthermore, this partnership harmoniously aligns with CareView's steadfast commitment to advancing virtual care solutions. These solutions are designed to elevate patient outcomes, streamline clinical workflows, prioritize patient safety, and drive notable cost efficiencies. By thoughtfully integrating technology, CareView aims to significantly contribute to fostering a safer healthcare environment for both patients and healthcare providers. About CareView Communications, Inc. For over a decade, CareView has been dedicated to supporting hospital care teams with its innovative virtual care solutions. The Company has established successful partnerships with over 200 hospitals nationwide, implementing effective inpatient virtual care strategies that greatly enhance patient safety and overcome critical staffing challenges. The CareView platform, fueled by industry-leading predictive technology and supported by its purpose-built hardware, specifically addresses the unique requirements of virtual nursing and virtual sitting use cases. The CareView team works closely with their hospital partners to understand their evolving needs and deliver tailored virtual care strategies that align with their objectives. By providing healthcare professionals with the tools they need to deliver exceptional care, CareView contributes to improved patient outcomes and a more sustainable healthcare ecosystem.

Read More

Digital Healthcare, Healthcare Analytics

Equum Medical Launches the Lighthouse Series™: Inspiring Success Stories in Telehealth and Healthcare Transformation

PRNewswire | July 24, 2023

Evidence is mounting from the experiences of hospitals large and small, urban and rural that telehealth is having a positive effect on staffing, patient safety, clinical services and hospital revenue, Equum Medical reports. The company, a leading provider of innovative telehealth services, has released the Equum Medical Lighthouse Series™. These customer success stories showcase the transformative power of telehealth in addressing key challenges faced by health systems and hospitals worldwide. The Series is intended to highlight real-world examples of how a complete acute care telehealth service using remote physicians, nurses and monitoring technologists supplements current hospital staff, provides specialist expertise and quickly moves patients to the most appropriate sites for care. In today's rapidly evolving healthcare landscape, health systems and hospitals are constantly seeking innovative solutions to enhance efficiency, reduce costs and improve patient outcomes. The Equum Medical Lighthouse Series brings to the forefront some of the most pressing challenges faced by healthcare providers, including ED capacity, ICU mortality and length of stay, physician and nurse burnout, and rural hospital specialist access. Telehealth offers a promising solution by increasing access to care in underserved areas, alleviating the shortage of clinicians and reducing costs to make healthcare more accessible and affordable. Dr. Scurlock, CEO and Founder of Equum Medical, emphasized the importance of sharing these success stories: "We are thrilled to launch the Equum Medical Lighthouse Series. By showcasing real-world examples of how telehealth has successfully addressed critical challenges, we aim to encourage broader adoption of telehealth and the dissemination of information on successful strategies." The series aims to provide healthcare leaders with actionable insights and evidence-based strategies to navigate their own telehealth implementations by demonstrating the tangible benefits that can be achieved by embracing telehealth and leveraging its potential to drive positive change in healthcare delivery. Healthcare providers, administrators and industry professionals can gain a valuable resource for understanding the diverse applications of telehealth and the significant impact it can have on healthcare delivery, patient outcomes and the overall well-being of both patients and providers. "We are going to continue to grow the Lighthouse Series as we get additional results from our engagements," said Karsten Russell-Wood, MBA, MPH, Equum's Chief Marketing Officer. "We want this to be a resource for innovators and evidence of what our model of care can do to ease the pressure on hospitals and health systems in this time of profound change for our industry." Equum Medical is an active member of the American Telemedicine Association and the National Rural Health Association, through which participating hospital systems can access thought leadership and engage with Equum Medical executives to expand telehealth understanding and applications. About Equum Equum Medical is a nationally recognized, tech-enabled clinical services company that provides the people and processes that ensure investments in telehealth technology succeed in transforming inpatient care. Equum's clinical services platform focuses on the acute care population spanning ED, ICU, nursing and sitter solutions.

Read More